期刊文献+

人ALK-1的克隆和真核表达载体的构建 被引量:1

Cloning of human full-length ALK-1 in HEK293 cells and construction of eukaryotic expression vector
下载PDF
导出
摘要 目的:克隆人ALK-1基因并构建其真核表达载体.方法:设计ALK-1特异性引物,提取人胚胎肺组织总RNA,用RT-PCR方法获取人ALK-1 cDNA.将ALK-1 cDNA克隆至pcDNA3.1/myc-His(-),双酶切鉴定并测序后,转染HEK293细胞.用Western Blot检测目的蛋白的表达.结果:成功获得人ALK-1全长cDNA,双酶切鉴定证实成功构建pcDNA3.1(-)/ALK-1.测序结果表明ALK-1全长cDNA与GeneBank中ALK-1序列完全一致.转染HEK293细胞后,可检测出Mr约为62×103的目的蛋白.结论:获得了ALK-1全长cDNA并成功构建了ALK-1真核表达载体,证实pcDNA3.1(-)/ALK-1转染HEK293细胞后可表达ALK-1蛋白,为深入研究ALK-1介导的TGFβ信号转导通路在创面愈合以及瘢痕疙瘩发生,发展中的作用奠定了基础. AIM: To clone and express human full-length ALK-1 cDNA in HEK293 cells. METHODS. Human ALK-1 specific primers were designed to obtain full-length cDNA through RT-PCR from lung tissues of human embryos and it was then cloned into vector pcDNA3. 1/myc-His (-) A. The recombinant plasmid pcDNA3.1 ( - )/ALK-1 was transfected into HEK293 cells after it was verified by restriction enzyme digestion and DNA sequencing. The expression of ALK-1 gene was detected by Western Blot using mouse anti-6XHis antibody. RESULTS: A 1.7 Kb full-length ALK-1 cDNA was obtained by RT-PCR and inserted into pcDNA 3.1/myc-His( - ). DNA sequencing results confirmed that the sequence of ALK-1 was consistent with that reported. Western Blot showed that a Mr 62 × 10^3 ALK- protein could be expressed after transfecting pcDNA3-1( - )/ALK-1 into HEK293 cells. CONCLUSION: Human full-length ALK-1 cDNA is successfully cloned and can be expressed in transfected HEK293 cells, which provides a solid basis for exploring the effects of ALK-1 mediated TGFβ signal pathway in wound healing and the development of keloid.
出处 《第四军医大学学报》 北大核心 2005年第22期2046-2048,共3页 Journal of the Fourth Military Medical University
基金 陕西省攻关计划[2004K16-G1(5)]
关键词 ALK-1 克隆 分子 基因表达 ALK-1 cloning, molecular gene expression
  • 相关文献

参考文献10

  • 1Wu X, Robinson CE, Fong HW, et al. Cloning and characterization of the murine activin receptor like kinase-1 (ALK-1) homolog [J]. Biochem Biophys Res Commun, 1995; 216(1): 78-83.
  • 2ten Dijke P, Ichijo H, Franzen P, et al. Activin receptor-like kinases: A novel subclass of cell-surface receptors with predicted serine/threonine kinase activity [J]. Oncogene, 1993; 8(10): 2879-2887.
  • 3Gold LI, Sung JJ, Siebert JW, et al. Type I (RI) and type II (RII) receptors for transforming growth factor-beta isoforms are expressed subsequent to transforming growth factor-beta ligands during excisional wound repair [J]. Am J Pathol, 1997; 150(1): 209-222.
  • 4Goumans MJ, Valdimarsdottir G, Itoh S, et al. Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling [J]. Mol Cell, 2003; 12(4): 817-828.
  • 5Ten DP, Hill CS. New insights into TGF-beta-Smad signalling [J]. Trends Biochem Sci, 2004; 29(5): 265-273.
  • 6Leask A, Abraham DJ. TGF-beta signaling and the fibrotic response [J]. FASEB J, 2004; 18(7): 816-827.
  • 7Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling [J]. Nature, 2003; 425(6958): 577-584.
  • 8Goumans MJ, Lebrin F, Valdimarsdottir G. Controlling the angiogenic switch: A balance between two distinct TGF-b receptor signaling pathways [J]. Trends Cardiovasc Med, 2003; 13(7): 301-307.
  • 9Goumans MJ, Valdimarsdottir G, Itoh S, et al. Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors [J]. EMBO J, 2002; 21(7): 1743-1753.
  • 10Ota T, Fujii M, Sugizaki T, et al. Targets of transcriptional regulation by two distinct type I receptors for transforming growth factor-beta in human umbilical vein endothelial cells [J]. J Cell Physiol, 2002; 193(3): 299-318.

同被引文献9

  • 1张明烽,唐爽,宋红卫,张涌.人胎盘TRAIL基因的cDNA克隆及序列测定[J].西北农林科技大学学报(自然科学版),2005,33(2):6-8. 被引量:1
  • 2何晓宁,彭树英,杨瑞锋,刘凤军,郑月茂,张涌.人溶菌酶基因cDNA的克隆和序列分析[J].安徽农业科学,2006,34(11):2333-2335. 被引量:3
  • 3Goumans M J,Lebrin F,Valdmarsdottir G. Controlling the angiogenic switch:A balance between two distinct TGF-b receptor signaling pathways[J]. Trends Cardiovasc Med, 2003, 13 (7):301-307.
  • 4Ozoren N, Kim K,Burns T F, et al. The caspase 9 inhibitor z- LEHD-FMK protects human liver cells while permitting death of cancer cells exposed to tumor necrosis factor-related apoptosis-inducing ligand[J]. Cancer Res, 2000, 60(22): 6259-6265.
  • 5Laeour S, Hammann A, Wotawa A, et al. Antieancer agents sensitize tumor cells to tumor necrosis factor-related apoptosis- inducing ligand-mediated caspase-8 activation and apoptosis[J]. Cancer Res, 2001, 61(4) : 1645-1651.
  • 6Jo M , Kim T H, Seol D W, et al. Apoptosis induced in normal human hepatoeytes by tumor necrosis factor-relatde apoptosis-inducing ligand[J]. Nat Med,2000, 6(5):564-567.
  • 7符莉芳,宋志芳.溶菌酶的研究进展[J].浙江预防医学,2008,20(4):56-59. 被引量:21
  • 8荣晓花,凌沛学.溶菌酶的研究进展[J].中国生化药物杂志,1999,20(6):319-320. 被引量:53
  • 9孙怀昌,张泉,施伟庆,李国才,于峰.人溶菌酶cDNA的克隆及其在小鼠体内的表达[J].中国兽医学报,2004,24(2):157-159. 被引量:19

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部